PROSTATIC NEOPLASMS
Clinical trials for PROSTATIC NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new PROSTATIC NEOPLASMS trials appear
Sign up with your email to follow new studies for PROSTATIC NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Prostate cancer vaccine trial halted early – but data may still help
Disease control TerminatedThis study tested a treatment called PROSTVAC-V/F in 33 men who had their prostate removed but were at high risk of the cancer returning. The goal was to see if the treatment could keep cancer from coming back. The study was stopped early, so results are limited, but the informat…
Matched conditions: PROSTATIC NEOPLASMS
Phase: PHASE2 • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
Promising prostate cancer combo study halted before results
Disease control TerminatedThis study tested a combination of two drugs, cabozantinib and abiraterone, in men with a type of advanced prostate cancer that had spread to the bones and no longer responded to standard hormone therapy. The goal was to see if the combination could delay cancer growth or death. …
Matched conditions: PROSTATIC NEOPLASMS
Phase: PHASE2 • Sponsor: Exelixis • Aim: Disease control
Last updated May 19, 2026 11:47 UTC
-
Can a video game teach surgeons to remove prostate cancer?
Knowledge-focused TerminatedThis study looked at whether an online video simulator helps surgeons learn a specific type of prostate cancer surgery (laparoscopic radical prostatectomy). It involved 29 surgeons who were new to the procedure. The main goal was to see if the simulator reduced surgery time and c…
Matched conditions: PROSTATIC NEOPLASMS
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 26, 2026 05:54 UTC
-
Blood marker hunt for prostate cancer drug response fizzles
Knowledge-focused TerminatedThis study aimed to see if a substance in the blood called uPAR could predict how well men with advanced prostate cancer would respond to the drug abiraterone. Only 3 men were enrolled before the study was stopped early, so no clear conclusions can be drawn. The goal was to find …
Matched conditions: PROSTATIC NEOPLASMS
Sponsor: Kristoffer Rohrberg • Aim: Knowledge-focused
Last updated May 26, 2026 05:50 UTC